Dhananjay Taumar | Pharmaceutical Sciences | Best Academic Researcher Award

Published on | Editorial Board by World Top Scientists

Best Academic Researcher Award

Dhananjay Taumar –  IIMT University Meerut

 Dhananjay Taumar
Affiliation IIMT University Meerut
Country India
Scopus ID 58785853500
Documents 14
Citations 16
h-index 1
Subject Area Pharmaceutical Sciences
Event Name World Top Scientist Awards
ORCID 0009-0008-8967-4672

This article presents an academic overview of the research profile of Dhananjay Taumar, affiliated with IIMT University Meerut, in relation to the Best Academic Researcher Award. The summary follows a neutral encyclopedic style and highlights publicly available scholarly indicators including publication output, citations, research interests, and persistent researcher identifiers. The information is intended for academic reference and reflects recognized research indexing practices.[1]

Abstract

Dhananjay Taumar’s documented research activity is indexed through internationally recognized scholarly databases and reflects contributions within pharmaceutical sciences. Available metrics indicate fourteen indexed documents together with citation activity and an h-index that collectively provide measurable evidence of research dissemination. Such indicators are commonly used for institutional evaluation, research visibility, and academic recognition while being interpreted alongside qualitative scholarly assessment.[2]

Keywords

Pharmaceutical Sciences, Scopus, ORCID, Academic Research, Citation Analysis, Scholarly Publishing, Research Metrics, Research Evaluation.

Introduction

Academic awards frequently consider research productivity, publication quality, citation influence, and sustained scholarly engagement. International indexing platforms improve transparency by providing standardized author profiles and publication records that assist institutions and award committees in evidence-based evaluation. Persistent researcher identifiers further enhance attribution and long-term discoverability.[3]

Research Profile

The available profile indicates that Dhananjay Taumar is affiliated with IIMT University Meerut and conducts research within pharmaceutical sciences. The author’s Scopus profile and ORCID identifier contribute to reliable scholarly identification across publishers and indexing systems. These resources support research integrity, author disambiguation, and consistent academic reporting.[1]

Research Contributions

Research contributions in pharmaceutical sciences commonly include experimental studies, reviews, collaborative investigations, and scientific communication that advance understanding within the discipline. Indexed publications enable peer verification while citation records demonstrate continuing engagement by the scholarly community. These characteristics form important components of academic assessment.[4]

Publications

The publication record of Dhananjay Taumar reflects a consistent research focus on pharmaceutical sciences, nanotechnology-based drug delivery, neuropharmacology, and modern therapeutic strategies. Recent publications indexed through ORCID and Scopus include studies on silica-based nanocarriers, gene delivery, antimicrobial peptides, inflammatory disorders, and precision medicine. These scholarly works demonstrate interdisciplinary collaboration with researchers from multiple institutions while addressing contemporary healthcare challenges through evidence-based pharmaceutical research.[2]

Research Impact

The research impact of Dhananjay Taumar may be evaluated using internationally accepted scholarly indicators such as indexed publications, citation count, author profile visibility, and persistent digital identifiers. Available records indicate active publication in peer-reviewed journals together with measurable citation activity that contributes to the visibility of his scientific work. The combination of ORCID registration, Scopus indexing, and DOI-linked publications supports transparency, accessibility, and long-term discoverability of research outputs within the global academic community.[3]

Award Suitability

Recognition through academic awards generally considers research quality, publication consistency, citation performance, institutional affiliation, and scholarly contribution to the advancement of knowledge. Based on publicly available academic records, Dhananjay Taumar possesses verifiable research credentials supported by indexed publications and internationally recognized researcher identifiers. The final determination of eligibility for the World Top Scientist Awards remains subject to the official evaluation process and independent selection criteria established by the award organizing committee.[4]

Conclusion

The academic profile presented in this article summarizes publicly available information relating to Dhananjay Taumar’s scholarly activities, institutional affiliation, publication record, and research identifiers. The available evidence indicates ongoing contributions within pharmaceutical sciences through peer-reviewed publications and collaborative research initiatives. This information serves as an objective academic overview intended for reference purposes and supports transparent documentation of scholarly achievements within internationally recognized research databases.[5]

References

  1. Taumar, D., Singh, A. P., Sharma, H., Gohri, S., & Chaudhary, V. (2026). Silica based nanocarriers for combination immunotherapy targeting the tumor immune microenvironment. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-026-02131-8
  2. Taumar, D., Singh, A. P., Sharma, H., Shamim, Gohri, S., & Chaudhary, V. (2026). Mechanistic and safety evaluation of standardized traditional Chinese medicine formulations and their bioactive constituents in ICD-11-classified inflammatory skin diseases: A structured narrative review. https://doi.org/10.1016/j.prmcm.2026.100827
  3. Taumar, D., Kumar, A., Singh, A. P., & Dhama, N. (2026).
    ROS-responsive baicalin hydrogel from Scutellaria baicalensis for targeted modulation of cutaneous inflammation: Mechanistic insights and translational perspectives. https://doi.org/10.1016/j.prmcm.2026.100807
  4. Shamim, Singh, A. P., Sharma, H., Gohri, S., Taumar, D., & Chaudhary, V. (2026). Exosome mimetic nanoparticles for siRNA based targeting of α-synuclein and neuroinflammation in Parkinson’s disease. https://doi.org/10.1093/jpp/rgag052
  5. Kumar, S., Taumar, D., Gaikwad, S., More, A., Nema, V., & Mukherjee, A. (2024).
    Antiretroviral action of Rosemary oil-based atazanavir formulation and the role of self-nanoemulsifying drug delivery system in the management of HIV-1 infection. https://doi.org/10.1007/s13346-023-01492-8

Zaid Khan | Clinical Pharmacist | Young Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Zaid Khan | Clinical Pharmacist | Young Researcher Award

Zaid Khan | Aditya Bangalore Institute of Pharmacy Education and Research | India

Dr. Zaid Khan is a dedicated and emerging researcher in pharmaceutical sciences with a Doctor of Pharmacy background. He has gained valuable clinical and research experience through internships in reputed hospitals and research institutions, where he contributed to projects involving antibiotic prophylaxis, medication therapy management, and pain management. His work demonstrates strong analytical, clinical, and research design skills, complemented by effective communication and patient counseling abilities. Dr. Khan has published and presented research at national and international platforms and actively engages in professional development through workshops and conferences. His achievements, including recognition as a Young Researcher Award recipient, reflect his commitment to advancing clinical pharmacy and drug safety practices. With a strong interest in bridging research and clinical application, Dr. Khan aspires to contribute to innovative therapeutic strategies, pharmacovigilance, and evidence-based healthcare, positioning himself as a promising professional in the evolving field of pharmaceutical research.

Profiles: Google Scholar | ORCID

Featured Publications

1. Khan, Z., Krishna, D., Daga, S., Rastogih, N., Rekha, M., & Patel, K. (2023). Advancements in minimally invasive surgery: A comprehensive analysis of robotic surgery, endoscopic techniques, and natural orifice translumenal endoscopic surgery. Georgian Medical News, 87–92.

2. Khan, Z., Rekha, M. M., Hiremath, S. R. R., & Shapur, S. R. (2025). A comprehensive study on antibiotic prophylaxis practices across diverse surgical modalities. Journal of Pharmaceutical Care, 93–100.

3. Khan, Z., Ramya, C. V., PR, D. S., & Vishwanath, B. A. (2025). Development and computational analysis of polyherbal chewable lozenges for effective management of mouth and throat infections. Palestinian Medical and Pharmaceutical Journal.

4. Khan, Z. (2024). A case report of advanced periampullary carcinoma: Palliative chemotherapy following Whipple’s surgery. Research & Reviews: Journal of Oncology and Hematology, 13.

5. Zaid, K., & Khan, Z. (2023). Beyond chemotherapy: The promise of immunotherapy in cancer care and advancements in cancer therapy. Research & Reviews: A Journal of Immunology, 13(2), 22–37.

Sireen Abdulrahim Shilbayeh | Clinical Pharmacy | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Prof. Sireen Abdulrahim Shilbayeh | Clinical Pharmacy | Best Researcher Award

Professor at Princess Nora University, Pharmacy College, Riyadh, Saudi Arabia

Professor Sireen Abdulrahim Shilbayeh is a distinguished academic in clinical pharmacy with over two decades of experience in teaching, research, and healthcare practice. She earned her Ph.D. in Clinical Pharmacy Practice from the University of Nottingham, UK, specializing in pharmaceutical and health outcomes research, particularly the meta-analysis of antiarrhythmic drug trials. Currently a professor at Princess Nourah University in Riyadh, Saudi Arabia, she has held several key academic and administrative roles, including department head and scientific committee member. Her core strengths include evidence-based clinical practice, curriculum development, and interprofessional collaboration. She has been recognized with multiple institutional awards for research excellence and productivity. Her scholarly contributions span clinical trials, systematic reviews, and pharmacy education, supported by active participation in international conferences. Professor Shilbayeh is committed to advancing pharmacy practice through impactful research, academic leadership, and the mentoring of future healthcare professionals.

🔹Professional Profile 

Google Scholar
Scopus Profile 

🏆Strengths for the Award

Professor Shilbayeh demonstrates a distinguished and consistent record of academic and research achievements. Her doctoral training from the University of Nottingham, UK, focused on high-impact, evidence-based clinical pharmacy research, particularly in meta-analysis and systematic reviews—areas that are fundamental to improving clinical decision-making and healthcare outcomes.

Her long-standing academic trajectory, progressing from Assistant to Full Professor, across multiple universities, reflects both resilience and recognition of her scholarly contributions. She has served in prestigious roles, including chair memberships in university scientific councils and IRB committees, indicating peer trust and leadership in research governance.

Further, she has received multiple awards for research excellence from Princess Nourah University, particularly for prolific output in health sciences—a strong testament to her research productivity and impact. Her work on antiarrhythmic drug evaluations and pharmacoepidemiology, combined with over two decades of conference participation, showcases her dedication to scientific dissemination and continuing professional development.

🎓 Education

Professor Sireen Abdulrahim Shilbayeh holds a strong academic foundation in pharmaceutical sciences. She began her studies at King Saud University in Riyadh, Saudi Arabia, where she earned her Bachelor’s degree in Pharmacy. Seeking to further her education, she pursued postgraduate studies at the University of Nottingham in the United Kingdom. There, she completed an MPhil in Clinical Pharmacy, focusing on systematic reviews of clinical trials, followed by a Ph.D. in Clinical Pharmacy Practice. Her doctoral research specialized in the meta-analysis of randomized clinical trials involving antiarrhythmic drugs, combining rigorous scientific methodology with practical clinical implications. Throughout her academic journey, she developed a comprehensive understanding of clinical pharmacy, pharmacoepidemiology, and pharmaceutical care. Her education has been instrumental in shaping her evidence-based research approach, teaching philosophy, and ability to lead complex projects in academia and healthcare. These qualifications have paved the way for her successful academic and professional career in the region and beyond.

💼 Experience

Professor Shilbayeh brings over 25 years of academic and clinical experience in pharmacy. She began her professional career as a pharmacist at King Khaled University Hospital in Riyadh, gaining hands-on experience in inpatient and outpatient services, IV preparation, and drug information. She later worked as a clinical researcher at Nottingham University Hospital, focusing on cardiovascular pharmacotherapy. Her academic journey includes positions at Applied Science University and Al-Zytoonah University in Jordan, where she progressed from Assistant to Associate Professor. Since 2010, she has been affiliated with Princess Nourah University, where she became a Full Professor in 2015. Beyond teaching, she has served in several administrative capacities, including Head of the Clinical Pharmacy Practice Department, and as a member of the Institutional Review Board, Scientific Council, and Development Committees. Her career is marked by a blend of teaching excellence, research leadership, and a commitment to advancing clinical pharmacy education and healthcare practices.

🏅Awards and Honors

Professor Sireen Shilbayeh has received multiple accolades recognizing her contributions to research and academia. Among her most notable honors is the Excellence in Research Productivity Award from Princess Nourah University, awarded across all health-related faculties. This prestigious recognition highlights her extensive research output and impact within the healthcare sector. Additionally, she received an Appreciation Award from the University’s Graduate and Research Agency for her distinguished publications in indexed international journals. These awards reflect her dedication to scholarly excellence, continuous engagement with high-quality research, and leadership within the academic community. Her ability to maintain consistent output while supporting academic development and policy initiatives has earned her widespread respect. These honors also serve as acknowledgment of her commitment to raising standards in pharmacy practice and education, both regionally and internationally. Her achievements continue to inspire colleagues and students, solidifying her reputation as a leading figure in clinical pharmacy research.

🔬 Research Focus on Clinical Pharmacy

Professor Shilbayeh’s research centers on clinical pharmacy practice, with a strong emphasis on evidence-based medicine, pharmaceutical care, and health outcomes research. Her early work, including her doctoral dissertation, focused on the meta-analysis of antiarrhythmic drug trials, contributing valuable insights into cardiology-related pharmacotherapy. She is deeply involved in systematic reviews, pharmacoepidemiology, and comparative effectiveness research, ensuring her findings have direct clinical relevance. Her scholarly interests also span patient-centered care, drug safety, and therapeutic decision-making, aiming to improve the quality and efficiency of healthcare delivery. She frequently collaborates on projects addressing chronic disease management and clinical interventions in pharmacy practice. Through her work on the Institutional Review Board, she contributes to research ethics and the development of robust study designs. Her research not only informs clinical practice but also plays a key role in curriculum development and training for future pharmacists, emphasizing scientific rigor and real-world application.

📚 Publications Top Notes

  • Title: Prevalence of osteoporosis and its reproductive risk factors among Jordanian women: a cross-sectional study
    Authors: S. Shilbayeh
    Year: 2003
    Citations: 114

  • Title: Exploring knowledge and attitudes towards counselling about vitamin supplements in Jordanian community pharmacies
    Authors: S.A. Shilbayeh
    Year: 2011
    Citations: 42

  • Title: Validation of knowledge and adherence assessment tools among patients on warfarin therapy in a Saudi hospital anticoagulant clinic
    Authors: S.A.R. Shilbayeh, W.A. Almutairi, S.A. Alyahya, N.H. Alshammari, E. Shaheen, et al.
    Year: 2018
    Citations: 40

  • Title: University students’ knowledge, attitudes, and practices towards the national premarital screening program of Saudi Arabia
    Authors: M. Melaibari, S. Shilbayeh, A. Kabli
    Year: 2017
    Citations: 35

  • Title: Does COVID-19 lockdowns have impacted on global dengue burden? A special focus to India
    Authors: H. Sharma, A. Ilyas, A. Chowdhury, N.K. Poddar, A.A. Chaudhary, et al.
    Year: 2022
    Citations: 29

  • Title: The impact of CYP3A5 and MDR1 polymorphisms on tacrolimus dosage requirements and trough concentrations in pediatric renal transplant recipients
    Authors: S. Shilbayeh, R. Zmeili, R.I. Almardini
    Year: 2013
    Citations: 22

  • Title: A Markov Chain Model to Evaluate the Effect of CYP3A5 and ABCB1 Polymorphisms on Adverse Events Associated with Tacrolimus in Pediatric Renal Patients
    Authors: S.K.B. Sy, J. Heuberger, S. Shilbayeh, D.J. Conrado, H. Derendorf
    Year: 2013
    Citations: 19

  • Title: Pediatric renal transplantation in the Jordanian population: the clinical outcome measures during long-term follow-up period
    Authors: S. Shilbayeh, I. Hazza
    Year: 2012
    Citations: 17

  • Title: Quantitation of the impact of CYP3A5 A6986G polymorphism on quetiapine pharmacokinetics by simulation of target attainment
    Authors: S.A.R. Shilbayeh, S.K.B. Sy, M. Melhem, R. Zmeili, H. Derendorf
    Year: 2015
    Citations: 14

  • Title: Possible interethnic differences in omeprazole pharmacokinetics: comparison of Jordanian Arabs with other populations
    Authors: S. Shilbayeh, M.F. Tutunji
    Year: 2006
    Citations: 14

  • Title: Treatment satisfaction questionnaire for medication: validation of the translated Arabic version among patients undergoing warfarin therapy in Saudi Arabia
    Authors: S.A.R. Shilbayeh, S.A. Alyahya, N.H. Alshammari, W.A. Almutairi, E. Shaheen
    Year: 2018
    Citations: 10

  • Title: The impact of genetic polymorphisms on time required to attain the target tacrolimus levels and subsequent pharmacodynamic outcomes in pediatric kidney transplant patients
    Authors: S. Shilbayeh
    Year: 2014
    Citations: 10

  • Title: Influence of CYP3A5 6986A > G and ABCB1 3435C > T Polymorphisms on Adverse Events Associated With Tacrolimus in Jordanian Pediatric Renal Patients
    Authors: S.K.B. Sy, R.P. Singh, S. Shilbayeh, R. Zmeili, D. Conrado, H. Derendorf
    Year: 2013
    Citations: 9

  • Title: The anti-clot treatment scale (ACTS): validation of the translated Arabic version among patients undergoing warfarin therapy in Saudi Arabia
    Authors: S.A.R. Shilbayeh, A.A. Ibrahim
    Year: 2020
    Citations: 7

  • Title: Patient experience with an educational mobile health application: A pilot study on usability and feasibility in a Saudi population
    Authors: I.S.A. Shilbayeh, S.A. Shilbayeh
    Year: 2020
    Citations: 7

🏁 Conclusion

The Clinical Pharmacy Award is more than a recognition—it’s a platform to celebrate innovation, dedication, and impact in pharmaceutical care. By honoring professionals who excel in clinical practice, education, and research, this award promotes advancement in healthcare delivery and encourages the adoption of evidence-based, patient-centered approaches. Whether you’re an academic, clinician, or researcher, this is your opportunity to showcase your contributions to the evolving field of pharmacy. Apply now, inspire others, and join a distinguished network of leaders shaping the future of clinical pharmacy.